GGrantIndex
← Leaderboards

Baozhong Wang

Georgia State University

$13,120,260
Attributed
$13,420,260
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200823
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$13,420,260 · 5

By mechanism

R01$12,398,260 · 3
R43$600,000 · 1
R21$422,000 · 1

Top collaborators

Most similar at Georgia State University

Same institution · by research overlap

Others in their field

Top investigators on “Virus

Research focus

VirusImmune ResponseAntigensImmuneInfectionProteinsImmunityVaccinesPreventInfluenzaImmunizationInfluenza A VirusInfluenza Virus VaccineIntramuscularDesignNovel VaccinesSeasonal InfluenzaStructureViralBasePandemic DiseaseSuccessInfluenzavirusEpidemic

Grant awards (24)

Multivalent nanocluster universal influenza vaccine given by microneedle patch$768,852
R01 · FY2023 · AI · contact PI
Novel Influenza nano vaccines for broad cross protection$646,873
R01 · FY2023 · AI · contact PI
Multivalent nanocluster universal influenza vaccine given by microneedle patch$781,292
R01 · FY2022 · AI · contact PI
Novel Influenza nano vaccines for broad cross protection$663,476
R01 · FY2022 · AI · contact PI
Multivalent nanocluster universal influenza vaccine given by microneedle patch$761,509
R01 · FY2021 · AI · contact PI
Novel Influenza nano vaccines for broad cross protection$630,929
R01 · FY2021 · AI · contact PI
Multivalent nanocluster universal influenza vaccine given by microneedle patch$764,738
R01 · FY2020 · AI · contact PI
Novel Influenza nano vaccines for broad cross protection$652,846
R01 · FY2020 · AI · contact PI
Multivalent nanocluster universal influenza vaccine given by microneedle patch$778,900
R01 · FY2019 · AI · contact PI
Novel Influenza nano vaccines for broad cross protection$664,253
R01 · FY2019 · AI · contact PI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination$606,664
R01 · FY2018 · AI · contact PI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination$606,664
R01 · FY2017 · AI · contact PI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination$606,664
R01 · FY2016 · AI · contact PI
Novel Influenza A Nanovaccines for Broad Cross Protection$597,227
R01 · FY2016 · AI · contact PI
Novel Preventive HIV Vaccines$227,000
R21 · FY2016 · AI · contact PI
Novel Influenza A Nanovaccines for Broad Cross Protection$588,555
R01 · FY2015 · AI · contact PI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination$403,720
R01 · FY2015 · AI · contact PI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination$221,210
R01 · FY2015 · AI · contact PI
Novel Preventive HIV Vaccines$195,000
R21 · FY2015 · AI · contact PI
Novel Influenza A Nanovaccines for Broad Cross Protection$579,189
R01 · FY2014 · AI · contact PI
Novel Influenza A Nanovaccines for Broad Cross Protection$521,571
R01 · FY2013 · AI · contact PI
Novel Influenza A Nanovaccines for Broad Cross Protection$553,128
R01 · FY2012 · AI · contact PI
Enhancement of mucosal antibody responses to HIV vaccine$300,000
R43 · FY2009 · AI
Enhancement of mucosal antibody responses to HIV vaccine$300,000
R43 · FY2008 · AI